Axsome Therapeutics, Inc. (AXSM): Shares Outstanding
50.88M
As of 2025-12-31
52.30M
As of 2026-06-30
+5.4%
3-year compound annual growth
+6.4%
5-year compound annual growth
+10.3%
10-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 50.88M | +4.6% | 2026-02-23, Balance as of period end |
| 2024-12-31 | 48.67M | +2.8% | 2026-02-23, Balance as of period end |
| 2023-12-31 | 47.35M | +8.9% | 2025-02-18, Balance as of period end |
| 2022-12-31 | 43.50M | +15.0% | 2024-02-23, Balance as of period end |
| 2021-12-31 | 37.82M | +1.2% | 2023-02-28, Balance as of period end |
| 2020-12-31 | 37.37M | +1.2% | 2022-03-01, Balance as of period end |
| 2019-12-31 | 36.93M | +22.8% | 2021-03-01, Balance as of period end |
| 2018-12-31 | 30.09M | +18.0% | 2020-03-12, Balance as of period end |
| 2017-12-31 | 25.49M | +33.1% | 2019-03-15, Balance as of period end |
| 2016-12-31 | 19.15M | 0.0% | 2018-03-07, Balance as of period end |
| 2015-12-31 | 19.15M | n/a | 2017-03-07, Balance as of period end |